Royalty Pharma plc Return on Assets (ROA) for the Trailing 12 Months (TTM) ending September 30, 2024: 6.72%

Royalty Pharma plc Return on Assets (ROA) is 6.72% for the Trailing 12 Months (TTM) ending September 30, 2024, a 3,601.56% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.
  • Royalty Pharma plc Return on Assets (ROA) for the Trailing 12 Months (TTM) ending September 30, 2023 was 0.18%.
  • Royalty Pharma plc Return on Assets (ROA) for the Trailing 12 Months (TTM) ending September 30, 2021 was 4.39%, a -68.97% change year over year.
  • Royalty Pharma plc Return on Assets (ROA) for the Trailing 12 Months (TTM) ending September 30, 2020 was 14.16%.
Key Data
Date Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share Dividend Per Share